XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.99

-1.5%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (14091)	7/12/2000 5:53:35 PM
From: Bluegreen	Read Replies (1) of 17367

George, I was passing by your clubhouse and heard you screaming to your members something about analysts and anti-cd11a. One analyst was referring to "experts." Why couldn't the volume increase be due to possible roll out of cancer product or products into human studies?????>>>>>>>>>>>>>>``All the experts feel this is the most exciting compound in clinical trials for psoriasis,'' said Matthew Geller, an analyst with CIBC World Markets, who rates the stock a ``buy.'' ``They could have a real blockbuster with this drug.'' The company also has two other antibody products for treating cancer, which could move into human studies over the next 12 to 18 months, Augustine said in his report.<<<<<<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next